A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients

Clinical trial NCT05375136 · COMPLETED

Trial details

NCT number: NCT05375136
Sponsor: Eisai Korea Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Endometrial Neoplasms Endometrium Carcinoma Renal Cell Carcinoma

Start date: 2021-06-25
Primary completion: 2023-11-07
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.